Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Advocacy"

U.S. Doctor Group Calls for Ban on Drug Advertising to Consumers

Susan Kelly  |  November 19, 2015

(Reuters)—The American Medical Association on Tuesday called for a ban on advertising prescription drugs and medical devices directly to consumers, saying the ads drive patients to demand expensive treatments over less costly ones that are also effective. The influential doctors’ group said the new policy reflects physicians’ concerns that marketing spending on a proliferation of…

Dr. St.Clair Reflects on Progress in Rheumatology

E. William St.Clair, MD  |  November 17, 2015

As a practicing rheumatologist, I have experienced the increasing payer and government involvement shaping our evolving healthcare system. New payment models, changes in health insurance coverage, the federal mandate for the adoption of electronic health records and the implementation of ICD-10 are recent changes that have rocked our world. Our patients are also paying the…

Ethics Forum: Personal Ethics Questions Surrounding RheumPAC Donations

Matthew L. Mundwiler, MD, & Robert H. Shmerling, MD  |  October 14, 2015

Imagine you’ve just heard a compelling presentation urging all ACR members to contribute to RheumPAC, the ACR’s political action committee. RheumPAC’s mission is to support politicians who support issues important to rheumatologists. You are impressed by the role RheumPAC has played in a number of issues you support. Just as you’re writing a check, you…

Why Rheumatologists Should Join the AMA

Gary Bryant, MD  |  October 14, 2015

Editor’s note: Welcome to the first installment of Experiences in Advocacy, a special series authored by ACR members detailing personal experiences in advocacy. We need rheumatologists to join the American Medical Association (AMA). Here’s why, and how to do it. Having participated in your delegation for over a decade, I have seen major improvements in…

Rheumatologists, Patient Advocacy Efforts Make a Difference

E. William St.Clair, MD  |  September 15, 2015

We’re in this together for rheumatology and our patients. Those who know me appreciate my devotion to Duke Basketball and my pride in their recent NCAA championship. Coach K (Krzyzewski), a firmly established leader in the world of college basketball, makes the analogy that a basketball team is like five fingers on a hand, and…

Congress’ District Workweeks in August Prime Time for Rheumatology Advocacy

From the College  |  August 17, 2015

Each year in August, lawmakers return home for the summer recess and convene district workweeks. That means you have the opportunity to meet with members in their local offices, attend fund-raisers nearby or participate in a town hall. This is where our strength as a membership organization can benefit us most. We have real physicians…

How to Launch Successful Rheumatology Patient Advocacy Programs

Christopher Adams, MD  |  July 14, 2015

Editor’s note: This is the second installment of a two-part series showing how a busy office-based practice can incorporate patient advocacy into its standard workflow. In Part 1, we looked at the reasons for incorporating patient advocacy into your practice and offered an outline for implementing it. Part 2 amplifies the concepts explored in Part…

The ACR Partners with Coalition, Patient Advocacy Groups to Advocate for Rheumatology

Chris Morris, MD, RheumPAC Committee  |  July 13, 2015

In terms of getting our message heard in Washington, D.C., rheumatology faces a David vs. Goliath battle on several levels. Many industries have far greater resources, use multiple lobbying firms, and have advertising and lobbying budgets that eclipse ours by several hundred-fold. Rheumatology is far smaller than most other medical specialties; our membership is a…

RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts

From the College  |  June 15, 2015

Dear ACR and ARHP Colleagues, In 2007, the ACR created RheumPAC as the need for strong advocacy for rheumatologists and their patients and rheumatology training and research became compelling. The Government Affairs Committee was adept at developing novel ideas and strong policies, but there was a notable gap between policy and politics. RheumPAC was started…

How Rheumatologists Can Mobilize Patients as Advocates, Activists

Christopher D. Adams, MD  |  June 15, 2015

Editor’s note: This is the first installment of a two-part series showing how a busy office-based practice can incorporate patient advocacy into its standard workflow. Part 1 outlines the reasons for advocacy and the benefits to both patients and doctors, then gives a quick-start outline to get you started. Part 2 will amplify the concepts…

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences